Transcriptomic and Proteomic Analyses Identify THBS2, VWF, NFASC, and AKR1B10 as Diagnostic Biomarkers for Advanced Fibrosis in NAFLD
Shan Ding, Yiqing Liu, Zhi Liu, Fulu Chu, Bingru Lu, Li Xu · 2026
Read Transcriptomic and Proteomic Analyses Identify THBS2, VWF, NFASC, and AKR1B10 as Diagnostic Biomarkers for Advanced Fibrosis in NAFLD by Shan Ding, Yiqing Liu, Zhi Liu, Fulu Chu, Bingru Lu, Li Xu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13213171.txt.
Description
Shan Ding and colleagues hunt in 2026 for blood markers that can stage scarring in fatty liver disease without a biopsy. Liver sampling remains the standard for judging advanced scarring, yet patients dislike it and doctors need a gentler option.
The team combined liver gene-activity data with blood protein data, screened candidates with three machine-learning methods, and checked four finalists in 119 biopsy-confirmed patients. Together the four proteins separated advanced scarring from earlier stages with strong accuracy, matching established non-invasive scores. Levels of three rose steadily in mice fed a fatty diet. Single-cell and genetic analyses added clues about where the markers act and whether they might help cause disease.
Catalog record
| CREATOR | Shan Ding, Yiqing Liu, Zhi Liu, Fulu Chu, Bingru Lu, Li Xu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 53 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |